FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292820683> ?p ?o ?g. }

• W4292820683 endingPage "99" @default.
• W4292820683 startingPage "89" @default.
• W4292820683 abstract "Background A missense mutation in the α1c subunit of voltage-gated L-type Ca2+ channel–coding CACNA1C-E1115K, located in the Ca2+ selectivity site, causes a variety of arrhythmogenic phenotypes. Objective We aimed to investigate the electrophysiological features and pathophysiological mechanisms of CACNA1C-E1115K in patient-specific induced pluripotent stem cell (iPSC)–derived cardiomyocytes (CMs). Methods We generated iPSCs from a patient carrying heterozygous CACNA1C-E1115K with overlapping phenotypes of long QT syndrome, Brugada syndrome, and mild cardiac dysfunction. Electrophysiological properties were investigated using iPSC-CMs. We used iPSCs from a healthy individual and an isogenic iPSC line corrected using CRISPR-Cas9–mediated gene editing as controls. A mathematical E1115K-CM model was developed using a human ventricular cell model. Results Patch-clamp analysis revealed that E1115K-iPSC-CMs exhibited reduced peak Ca2+ current density and impaired Ca2+ selectivity with an increased permeability to monovalent cations. Consequently, E1115K-iPSC-CMs showed decreased action potential plateau amplitude, longer action potential duration (APD), and a higher frequency of early afterdepolarization compared with controls. In optical recordings examining the antiarrhythmic drug effect, late Na+ channel current (INaL) inhibitors (mexiletine and GS-458967) shortened APDs specifically in E1115K-iPSC-CMs. The AP-clamp using a voltage command obtained from E1115K-iPSC-CMs with lower action potential plateau amplitude and longer APD confirmed the upregulation of INaL. An in silico study recapitulated the in vitro electrophysiological properties. Conclusion Our iPSC-based analysis in CACNA1C-E1115K with disrupted CaV1.2 selectivity demonstrated that the aberrant currents through the mutant channels carried by monovalent cations resulted in specific action potential changes, which increased endogenous INaL, thereby synergistically contributing to the arrhythmogenic phenotype. A missense mutation in the α1c subunit of voltage-gated L-type Ca2+ channel–coding CACNA1C-E1115K, located in the Ca2+ selectivity site, causes a variety of arrhythmogenic phenotypes. We aimed to investigate the electrophysiological features and pathophysiological mechanisms of CACNA1C-E1115K in patient-specific induced pluripotent stem cell (iPSC)–derived cardiomyocytes (CMs). We generated iPSCs from a patient carrying heterozygous CACNA1C-E1115K with overlapping phenotypes of long QT syndrome, Brugada syndrome, and mild cardiac dysfunction. Electrophysiological properties were investigated using iPSC-CMs. We used iPSCs from a healthy individual and an isogenic iPSC line corrected using CRISPR-Cas9–mediated gene editing as controls. A mathematical E1115K-CM model was developed using a human ventricular cell model. Patch-clamp analysis revealed that E1115K-iPSC-CMs exhibited reduced peak Ca2+ current density and impaired Ca2+ selectivity with an increased permeability to monovalent cations. Consequently, E1115K-iPSC-CMs showed decreased action potential plateau amplitude, longer action potential duration (APD), and a higher frequency of early afterdepolarization compared with controls. In optical recordings examining the antiarrhythmic drug effect, late Na+ channel current (INaL) inhibitors (mexiletine and GS-458967) shortened APDs specifically in E1115K-iPSC-CMs. The AP-clamp using a voltage command obtained from E1115K-iPSC-CMs with lower action potential plateau amplitude and longer APD confirmed the upregulation of INaL. An in silico study recapitulated the in vitro electrophysiological properties. Our iPSC-based analysis in CACNA1C-E1115K with disrupted CaV1.2 selectivity demonstrated that the aberrant currents through the mutant channels carried by monovalent cations resulted in specific action potential changes, which increased endogenous INaL, thereby synergistically contributing to the arrhythmogenic phenotype." @default.
• W4292820683 created "2022-08-24" @default.
• W4292820683 creator A5016134558 @default.
• W4292820683 creator A5017172773 @default.
• W4292820683 creator A5026028224 @default.
• W4292820683 creator A5033616120 @default.
• W4292820683 creator A5036233881 @default.
• W4292820683 creator A5040877327 @default.
• W4292820683 creator A5041966807 @default.
• W4292820683 creator A5045030643 @default.
• W4292820683 creator A5046125720 @default.
• W4292820683 creator A5049463474 @default.
• W4292820683 creator A5053398138 @default.
• W4292820683 creator A5053824352 @default.
• W4292820683 creator A5057435851 @default.
• W4292820683 creator A5062554952 @default.
• W4292820683 creator A5063139888 @default.
• W4292820683 creator A5065735302 @default.
• W4292820683 creator A5067915777 @default.
• W4292820683 creator A5077457361 @default.
• W4292820683 creator A5080893071 @default.
• W4292820683 creator A5084522717 @default.
• W4292820683 creator A5085128848 @default.
• W4292820683 creator A5085426100 @default.
• W4292820683 creator A5086167197 @default.
• W4292820683 creator A5090316816 @default.
• W4292820683 date "2023-01-01" @default.
• W4292820683 modified "2023-10-14" @default.
• W4292820683 title "Disrupted CaV1.2 selectivity causes overlapping long QT and Brugada syndrome phenotypes in the CACNA1C-E1115K iPS cell model" @default.
• W4292820683 cites W1449970176 @default.
• W4292820683 cites W1971343049 @default.
• W4292820683 cites W2009870567 @default.
• W4292820683 cites W2022614248 @default.
• W4292820683 cites W2030695893 @default.
• W4292820683 cites W2036937904 @default.
• W4292820683 cites W2044873676 @default.
• W4292820683 cites W2049034426 @default.
• W4292820683 cites W2061225022 @default.
• W4292820683 cites W2070424623 @default.
• W4292820683 cites W2073709523 @default.
• W4292820683 cites W2083706353 @default.
• W4292820683 cites W2107038669 @default.
• W4292820683 cites W2107517361 @default.
• W4292820683 cites W2117809133 @default.
• W4292820683 cites W2124912765 @default.
• W4292820683 cites W2148036689 @default.
• W4292820683 cites W2170271247 @default.
• W4292820683 cites W2593518655 @default.
• W4292820683 cites W2889402098 @default.
• W4292820683 cites W2937585450 @default.
• W4292820683 cites W2964944932 @default.
• W4292820683 doi "https://doi.org/10.1016/j.hrthm.2022.08.021" @default.
• W4292820683 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36007726" @default.
• W4292820683 hasPublicationYear "2023" @default.
• W4292820683 type Work @default.
• W4292820683 citedByCount "3" @default.
• W4292820683 countsByYear W42928206832023 @default.
• W4292820683 crossrefType "journal-article" @default.
• W4292820683 hasAuthorship W4292820683A5016134558 @default.
• W4292820683 hasAuthorship W4292820683A5017172773 @default.
• W4292820683 hasAuthorship W4292820683A5026028224 @default.
• W4292820683 hasAuthorship W4292820683A5033616120 @default.
• W4292820683 hasAuthorship W4292820683A5036233881 @default.
• W4292820683 hasAuthorship W4292820683A5040877327 @default.
• W4292820683 hasAuthorship W4292820683A5041966807 @default.
• W4292820683 hasAuthorship W4292820683A5045030643 @default.
• W4292820683 hasAuthorship W4292820683A5046125720 @default.
• W4292820683 hasAuthorship W4292820683A5049463474 @default.
• W4292820683 hasAuthorship W4292820683A5053398138 @default.
• W4292820683 hasAuthorship W4292820683A5053824352 @default.
• W4292820683 hasAuthorship W4292820683A5057435851 @default.
• W4292820683 hasAuthorship W4292820683A5062554952 @default.
• W4292820683 hasAuthorship W4292820683A5063139888 @default.
• W4292820683 hasAuthorship W4292820683A5065735302 @default.
• W4292820683 hasAuthorship W4292820683A5067915777 @default.
• W4292820683 hasAuthorship W4292820683A5077457361 @default.
• W4292820683 hasAuthorship W4292820683A5080893071 @default.
• W4292820683 hasAuthorship W4292820683A5084522717 @default.
• W4292820683 hasAuthorship W4292820683A5085128848 @default.
• W4292820683 hasAuthorship W4292820683A5085426100 @default.
• W4292820683 hasAuthorship W4292820683A5086167197 @default.
• W4292820683 hasAuthorship W4292820683A5090316816 @default.
• W4292820683 hasConcept C104317684 @default.
• W4292820683 hasConcept C107459253 @default.
• W4292820683 hasConcept C118441451 @default.
• W4292820683 hasConcept C126322002 @default.
• W4292820683 hasConcept C127716648 @default.
• W4292820683 hasConcept C145103041 @default.
• W4292820683 hasConcept C146403970 @default.
• W4292820683 hasConcept C147944092 @default.
• W4292820683 hasConcept C169760540 @default.
• W4292820683 hasConcept C185263204 @default.
• W4292820683 hasConcept C2777382798 @default.
• W4292820683 hasConcept C2777561782 @default.
• W4292820683 hasConcept C2779703243 @default.
• W4292820683 hasConcept C54355233 @default.
• W4292820683 hasConcept C71924100 @default.
• W4292820683 hasConcept C75563809 @default.

• next